Jounce Therapeutics
Why Robinhood?
You can watch JNCE and buy or sell other stocks, ETFs, and their options commission-free!About JNCE
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors.
JNCE Key Statistics
Stock Snapshot
Jounce Therapeutics(JNCE) stock is priced at $1.88, giving the company a market capitalization of 98.95M. It carries a P/E multiple of -1.91.
On 2026-02-11, Jounce Therapeutics(JNCE) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.01M.
The stock's 52-week range extends from a low of $0.58 to a high of $5.87.
The stock's 52-week range extends from a low of $0.58 to a high of $5.87.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.